INNOCAN PHARMA Corp SEC filings INNPF
INNOCAN PHARMA Corp has 48 filings in SEC EDGAR's recent list, going back to Oct 26, 2021. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| FWP | Free writing prospectus | Apr 3, 2026 | — |
| F-1/A | Filing | Apr 3, 2026 | — |
| FWP | Free writing prospectus | Mar 16, 2026 | — |
| F-1 | Registration statement (foreign issuer) | Mar 16, 2026 | — |
| F-1/A | Filing | Jan 7, 2026 | — |
| FWP | Free writing prospectus | Jan 6, 2026 | — |
| F-1/A | Filing | Jan 6, 2026 | — |
| FWP | Free writing prospectus | Dec 10, 2025 | — |
| F-1/A | Filing | Dec 10, 2025 | — |
| F-1/A | Filing | Oct 22, 2025 | — |
| FWP | Free writing prospectus | Oct 1, 2025 | — |
| F-1/A | Filing | Sep 30, 2025 | — |
| FWP | Free writing prospectus | Sep 12, 2025 | — |
| FWP | Free writing prospectus | Sep 5, 2025 | — |
| F-1/A | Filing | Sep 5, 2025 | — |
| F-1/A | Filing | Aug 4, 2025 | — |
| F-1 | Registration statement (foreign issuer) | Jul 23, 2025 | — |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INNPF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Calgary
- SEC CIK
- 1889791
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.